March 6, 2017 / 1:57 PM / 6 months ago

BRIEF-Psivida says enters funded feasibility study agreement

March 6 (Reuters) - Psivida Corp

* On March 2, entered into a funded feasibility study agreement with "a leading biopharmaceutical company" - SEC Filing

* Under work plan, co's Durasert sustained release drug technology to be formulated with certain of biopharmaceutical co's proprietary molecules Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below